No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr5:59471600-59500800 |
Weak transcription |
Primary B cells from cord blood |
blood
|
2 |
chr5:59482000-59492000 |
Weak transcription |
Primary neutrophils fromperipheralblood |
blood
|
3 |
chr5:59483200-59492000 |
Weak transcription |
Monocytes-CD14+_RO01746 |
blood
|
4 |
chr5:59484400-59492200 |
Weak transcription |
Aorta |
Aorta
|
5 |
chr5:59487000-59491400 |
Weak transcription |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
6 |
chr5:59491400-59493800 |
Enhancers |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
7 |
chr5:59491600-59492000 |
Enhancers |
A549 |
lung
|
8 |
chr5:59491600-59494000 |
Enhancers |
Hela-S3 |
cervix
|
9 |
chr5:59491800-59492200 |
Enhancers |
Cortex derived primary cultured neurospheres |
brain
|
10 |
chr5:59491800-59492400 |
Enhancers |
ES-I3 Cell Line |
embryonic stem cell
|
11 |
chr5:59491800-59492400 |
Enhancers |
Placenta Amnion |
Placenta Amnion
|
12 |
chr5:59491800-59492600 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
13 |
chr5:59491800-59492800 |
Enhancers |
HMEC |
breast
|
14 |
chr5:59491800-59493000 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
15 |
chr5:59491800-59493200 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
16 |
chr5:59492000-59492200 |
Active TSS |
Osteobl |
bone
|
17 |
chr5:59492000-59492400 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
18 |
chr5:59492000-59492400 |
Enhancers |
Monocytes-CD14+_RO01746 |
blood
|
19 |
chr5:59492000-59492800 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
20 |
chr5:59492000-59492800 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
21 |
chr5:59492000-59492800 |
Flanking Active TSS |
A549 |
lung
|
22 |
chr5:59492000-59492800 |
Enhancers |
HSMMtube |
muscle
|
23 |
chr5:59492000-59492800 |
Enhancers |
HUVEC |
blood vessel
|
24 |
chr5:59492000-59492800 |
Enhancers |
NH-A |
brain
|
25 |
chr5:59492000-59492800 |
Enhancers |
NHEK |
skin
|
26 |
chr5:59492000-59493000 |
Enhancers |
HSMM |
muscle
|
27 |
chr5:59492200-59492400 |
Enhancers |
Aorta |
Aorta
|
28 |
chr5:59492200-59492400 |
Flanking Active TSS |
Osteobl |
bone
|
29 |
chr5:59492200-59492600 |
Enhancers |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
30 |
chr5:59492200-59492600 |
Enhancers |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
31 |
chr5:59492200-59492800 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
32 |
chr5:59492200-59493200 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
33 |
chr5:59492400-59492800 |
Enhancers |
Brain Hippocampus Middle |
brain
|
34 |
chr5:59492400-59492800 |
Enhancers |
Osteobl |
bone
|
35 |
chr5:59492600-59493000 |
Weak transcription |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
36 |
chr5:59492600-59493000 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
37 |
chr5:59492600-59493000 |
Enhancers |
NHDF-Ad |
bronchial
|
38 |
chr5:59492600-59494600 |
Weak transcription |
Primary monocytes fromperipheralblood |
blood
|
39 |
chr5:59492600-59494800 |
Weak transcription |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
40 |
chr5:59492800-59493200 |
Enhancers |
A549 |
lung
|
41 |
chr5:59493000-59494400 |
Enhancers |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
42 |
chr5:59493200-59493400 |
Flanking Active TSS |
A549 |
lung
|
43 |
chr5:59493400-59493600 |
Enhancers |
A549 |
lung
|
44 |
chr5:59493600-59493800 |
Flanking Active TSS |
A549 |
lung
|
45 |
chr5:59493800-59498200 |
Weak transcription |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
46 |
chr5:59494000-59494400 |
Weak transcription |
Hela-S3 |
cervix
|
47 |
chr5:59494400-59495200 |
Enhancers |
Hela-S3 |
cervix
|